Hyperhidrosis Treatments
Find Hyperhidrosis Treatments
Brand Name
Sofdra
Generic Name
Sofpironium
View Brand Information FDA approval date: August 06, 2024
Form: Gel
What is Sofdra (Sofpironium)?
SOFDRA is indicated for the treatment of primary axillary hyperhidrosis in adults and pediatric patients 9 years of age and older. SOFDRA is an anticholinergic indicated for the treatment of primary axillary hyperhidrosis in adults and pediatric patients 9 years of age and older .
Approved To Treat
Save this treatment for later
Not sure about your diagnosis?
Tired of the same old research?
Related Clinical Trials
There is no clinical trials being done for this treatment